ALKS - Alkermes Incorporated

Your Recent Quotes: 0 | 0

Alkermes Incorporated

TRADE NOW Related Information and Financials
Price Glossary Definition
6.37 0.27
4.43%
11/21/08 4:00
Open
6.18
Prev Close
6.10
Volume
1,623,613
52 Wk. Range
5.55- 17.04
Year-to-Date Performance Glossary Definition
DOWN -59.14%
Latest Dividend
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
3.48
 
3.50
 
13.40
ALKS
Sect. Av.
S&P 500
Market Cap
604,716,800
Outstanding Shares
99,700,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy ALKS Rating Report
Target Price (1Yr)
High
24.00
Revenue
0

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
0.30
2.16
0.46
Net Income
1,667.90
-3.26
0.00
EPS
1,700.00
-3.02
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-56.81
-51.30
-66.35
Earnings Per Share($)

03/2006
 
 
 
0.04
03/2007
 
 
 
0.10
03/2008
 
 
 
1.66

Earnings
EBITDA
27,402,000
Revenue
240,717,000
Outside Analyst Rating History

11/23/08
3
Buy
11/23/08
5
Hold
11/23/08
1
Sell

Jim Cramer Portfolio
Find out now if ALKS is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Compare This Stock
Latest Headlines
The biotech's shares rise on news of an increased bet by investor Carl Icahn and an uptick in its diabetes drug's prescription data.

5:40PM 11/17/08

But the diabetes-drug maker still faces hurdles in winning back investor confidence.

3:19PM 11/17/08

Protherics is up 17%.

3:54PM 11/14/08

Shares of the drugmakers tumble on news their application for long-acting version of the diabetes drug Byetta don't meet FDA requirements.

12:48PM 11/04/08

Shares of the drugmakers tumble on news their application for long-acting version of the diabetes drug don't meet FDA requirements.

10:42AM 11/04/08

Gilead sinks on an FDA rejection.

4:08PM 09/17/08

Alkermes, BP, TAL International Group, Terex and MEMC Electronic Materials downgraded.

6:59AM 09/16/08

PepsiAmericas, Alkermes, American Medical Systems Holdings and Myriad Genetics upgraded; Akamai Technologies downgraded.

7:09AM 08/22/08

The medical device maker rose on an earnings beat.

4:12PM 08/19/08

Drug company says "no" to Roche's advances, says make a better offer worth considering.

5:16PM 08/13/08

Understanding the Market

Our Experts' Take at RealMoney
However, option traders boost January calls.

4:37PM 11/21/08

This market is producing a few stocks that could represent exceptional opportunities.

3:03PM 11/21/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading ALKS in his Action Alerts Plus Portfolio?

Premium Services